Literature DB >> 31063851

Sex hormone binding globulin for prediction of gestational diabetes mellitus in pre-conception and pregnancy: A systematic review.

Shahla Faal1, Parvin Abedi2, Shayesteh Jahanfar3, Jonas Mayoke Ndeke4, Zeynab Mohaghegh5, Foruzan Sharifipour6, Maryam Zahedian7.   

Abstract

AIM: The purpose of the present study was to assess the relationship of sex hormone binding globulin (SHBG) and gestational diabetes mellitus (GDM).
METHODS: The Cochrane Library, Medline, ScienceDirect, and Web of Science were searched for studies published from the inception of the databases up to February 2019. Our inclusion criteria were published observational full-text articles. All data were analyzed using Review Manager 5.3. Of 208 papers reviewed, 26 studies (n = 6668) were considered for meta-analysis.
RESULTS: The SHBG level was significantly lower in women with GDM compared to healthy women (MD = -11.86; 95% CI: [-13.02, -10.71]). Also, SHBG in women with PCOS and GDM and obesity was significantly lower than women with PCOS without GDM (MD = -38.14; 95% CI: [-56.79, -19.48]) and normal weight women (MD: -58.96; 95% CI: [-79.32, -38.59]). SHBG in the second trimester was lower than that in the first trimester and pre-conception.
CONCLUSIONS: This systematic review showed that the level of SHBG is significantly lower in GDM pregnant women than that in healthy women. The results of this systematic review about the relationship of GDM and SHBG and suggestion to assess this marker in early pregnancy should be considered with caution.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Gestational diabetes mellitus; Meta-analysis; Pregnancy; Sex hormone binding globulin; Systematic review

Mesh:

Substances:

Year:  2019        PMID: 31063851     DOI: 10.1016/j.diabres.2019.04.028

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  5 in total

Review 1.  Steroids, steroid associated substances and gestational diabetes mellitus.

Authors:  M Hill; A Pařízek; P Šimják; M Koucký; K Anderlová; H Krejčí; D Vejražková; L Ondřejíková; A Černý; R Kancheva
Journal:  Physiol Res       Date:  2021-12-30       Impact factor: 2.139

Review 2.  Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome.

Authors:  Xianqin Qu; Richard Donnelly
Journal:  Int J Mol Sci       Date:  2020-11-01       Impact factor: 5.923

3.  Maternal adiposity, smoking, and thyroid function in early pregnancy.

Authors:  Stine Linding Andersen; Louise Knøsgaard; Aase Handberg; Peter Vestergaard; Stig Andersen
Journal:  Endocr Connect       Date:  2021-09-13       Impact factor: 3.335

4.  Prediction of Insulin Resistance and Impaired Fasting Glucose Based on Sex Hormone-Binding Globulin (SHBG) Levels in Polycystic Ovary Syndrome.

Authors:  Aleksandra Biernacka-Bartnik; Piotr Kocełak; Aleksander Jerzy Owczarek; Piotr Choręza; Monika Puzianowska-Kuźnicka; Leszek Markuszewski; Paweł Madej; Jerzy Chudek; Magdalena Olszanecka-Glinianowicz
Journal:  Int J Endocrinol       Date:  2022-01-31       Impact factor: 3.257

Review 5.  Pathophysiological Role of Genetic Factors Associated With Gestational Diabetes Mellitus.

Authors:  B Ortega-Contreras; A Armella; J Appel; D Mennickent; J Araya; M González; E Castro; A M Obregón; L Lamperti; J Gutiérrez; E Guzmán-Gutiérrez
Journal:  Front Physiol       Date:  2022-04-04       Impact factor: 4.755

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.